สมาคมโรคติดเชื้อในเด็กแห่งประเทศไทย
PIDST
- HOME
- ประชาสัมพันธ์
-
เกี่ยวกับสมาคมฯ
- วิสัยทัศน์
- พันธกิจ
- Action plan
- ติดต่อสมาคม
- English Page
บทความสำหรับสมาชิก หน้าที่ 2
Cracking the Mystery: Unrecognized ID cases
A 4-year-old boy with progressive jaundice for 5 days PTA
Cracking the mystery: unrecognized ID case
CNS Infection: Current Best Practice and Future Directions
Infection Control Updates That Transformed Our Practice
CHANGING CLIMATE: ZIKA VIRUS ON THE RISE Impact of environmental shifts on vector-borne...
Vector-borne threats in a changing climate: Chikungunya on the rise
Vector-Borne Threats in a Changing Climate: Dengue, Chikungunya, and Zika on the Rise
Vector-Borne Threats in a Changing Climate: Dengue, Chikungunya, and Zika on the Rise
Facing the Challenge: Infections in Immunocompromised Children
ID Quiz I: Photo Quiz in Pediatric Infectious Disease 2026 Part V: Cardiovascular infec...
The next emerging infections: Building a smarter preparedness plan
The Next Emerging Infections: Building a Smarter Preparedness in a limited resource set...
The Next Emerging Infection: Building A Smarter Preparedness Plan
Global Gossips: What’s new in PID?
Post – COVID-19 Era :- Are we better prepared for the next pandemic?
Hot Topic in PID 2026
Vector-Borne Diseases: Current trends and Challenges
Vector-borne disease: Current trends and challenges
RSV VACCINATION IN PREGNANT WOMEN VS NIRSEVIMAB IN INFANTS
To Prevent RSV: Vaccination in Mom or Nirsevimab in Baby? (Pro)
Steroid treatment in Pediatric CAP OK vs not OK?
Steroid treatment in pediatric CAP: OK or not OK?
Vector-borne diseases: Current trends and challenge
RedBook 2024 Update: Key Changes and Clinical Highlights
Generative Al for Pediatrician in Practice
The exciting real case
New Guidelines: Key Updates to Enhance Your Practice
INTERESTING CASE
Believe it or not in COVID-19
THE POWER OF EVIDENCE: THE MOST INFLUENTIAL PUBLICATIONS FOR PEDIATRIC PRACTICE
Carbapenem-Resistant Acinetobacter baumannii and Difficult-to-Treat Pseudomonas aeruginosa
Attitudes and Eligibility of Long-Acting Cabotegravir/Rilpivirine Treatment Among Youth...
[1][2][3][4][5][6][7][8][9][10][11][12][13][14]
Cracking the Mystery: Unrecognized ID cases
A 4-year-old boy with progressive jaundice for 5 days PTA
Cracking the mystery: unrecognized ID case
CNS Infection: Current Best Practice and Future Directions
Infection Control Updates That Transformed Our Practice
CHANGING CLIMATE: ZIKA VIRUS ON THE RISE Impact of environmental shifts on vector-borne...
Vector-borne threats in a changing climate: Chikungunya on the rise
Vector-Borne Threats in a Changing Climate: Dengue, Chikungunya, and Zika on the Rise
Vector-Borne Threats in a Changing Climate: Dengue, Chikungunya, and Zika on the Rise
Facing the Challenge: Infections in Immunocompromised Children
ID Quiz I: Photo Quiz in Pediatric Infectious Disease 2026 Part V: Cardiovascular infec...
The next emerging infections: Building a smarter preparedness plan
The Next Emerging Infections: Building a Smarter Preparedness in a limited resource set...
The Next Emerging Infection: Building A Smarter Preparedness Plan
Global Gossips: What’s new in PID?
Post – COVID-19 Era :- Are we better prepared for the next pandemic?
Hot Topic in PID 2026
Vector-Borne Diseases: Current trends and Challenges
Vector-borne disease: Current trends and challenges
RSV VACCINATION IN PREGNANT WOMEN VS NIRSEVIMAB IN INFANTS
To Prevent RSV: Vaccination in Mom or Nirsevimab in Baby? (Pro)
Steroid treatment in Pediatric CAP OK vs not OK?
Steroid treatment in pediatric CAP: OK or not OK?
Vector-borne diseases: Current trends and challenge
RedBook 2024 Update: Key Changes and Clinical Highlights
Generative Al for Pediatrician in Practice
The exciting real case
New Guidelines: Key Updates to Enhance Your Practice
INTERESTING CASE
Believe it or not in COVID-19
THE POWER OF EVIDENCE: THE MOST INFLUENTIAL PUBLICATIONS FOR PEDIATRIC PRACTICE
Carbapenem-Resistant Acinetobacter baumannii and Difficult-to-Treat Pseudomonas aeruginosa
Attitudes and Eligibility of Long-Acting Cabotegravir/Rilpivirine Treatment Among Youth...